MIT study reveals non-invasive treatment holds promise for treating ‘chemo brain’
The gamma treatment also shows potential for treating patients living with neurological diseases
Read More
Tag: cognitive conditions
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
- Johnson & Johnson seeks EMA approval for teclistamab–daratumumab combination
- HUTCHMED begins phase 3 stage of pancreatic cancer trial
